首页> 外文OA文献 >Development of a novel oral vaccine against Mycobacterium avium paratuberculosis and Johne disease: A patho-biotechnological approach
【2h】

Development of a novel oral vaccine against Mycobacterium avium paratuberculosis and Johne disease: A patho-biotechnological approach

机译:新型抗禽分枝杆菌结核分枝杆菌和约翰病的口服疫苗的开发:一种病理生物技术方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mycobacterium avium subsp. paratuberculosis (MAP) is the etiological agent of Johne disease, a granulomatous enteritis of cattle and other domesticated and wild ruminant species. Johne disease is prevalent worldwide and has a significant impact on the global agricultural economy. Current vaccines against Johne are insufficient in stemming its spread, and associated side-effects prevent their widespread use in control programs. Effective and safe vaccine strategies are needed. The main purpose of this paper is to propose and evaluate the development of a novel oral subunit-vaccine using a patho-biotechnological approach. This novel strategy, which harnesses patho-genetic elements from the intracellular pathogen Listeria monocytogenes, may provide a realistic route towards developing an effective next generation subunit vaccine against Johne disease and paratuberculosis.
机译:鸟分枝杆菌亚种副结核病(MAP)是Johne病的病原体,Johne病是牛以及其他驯养和野生反刍动物的肉芽肿性肠炎。约翰病在世界范围内很普遍,并且对全球农业经济具有重大影响。当前针对约翰的疫苗不足以阻止其传播,并且相关的副作用阻止了它们在控制程序中的广泛使用。需要有效和安全的疫苗策略。本文的主要目的是使用病理生物技术方法提出并评估新型口服亚单位疫苗的开发。利用细胞内病原体单核细胞增生李斯特氏菌病原体的这一新策略,可以为开发有效的针对约翰氏病和副结核病的下一代亚单位疫苗提供一条现实的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号